Stock listing
IPSC Stock Price, News, Filings & Events — Century Therapeutics, Inc.
Selected listing: IPSC · NASDAQ · USD · US
This page tracks Century Therapeutics, Inc.'s IPSC:NASDAQ listing on NASDAQ in USD for US, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following IPSC:NASDAQ. IPSC:NASDAQ is the stock-level entry point for investors researching Century Therapeutics, Inc., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Century Therapeutics, Inc. is a public company traded under the ticker IPSC in the American market. The company has a market capitalization of approximately $380.5 million. Century Therapeutics focuses on developing innovative cell therapies for cancer treatment.

- Ticker
- IPSC:NASDAQ
- Asset type
- Stock
- Market cap
- $351.3M
- Sector
- Health Technology
- Industry
- Biotechnology
- Exchange
- NASDAQ
- Currency
- USD
Century Therapeutics, Inc. IPSC:NASDAQ stock context
This page tracks Century Therapeutics, Inc.'s IPSC:NASDAQ listing on NASDAQ in USD for US, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following IPSC:NASDAQ. IPSC:NASDAQ is the stock-level entry point for investors researching Century Therapeutics, Inc., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Century Therapeutics, Inc. is a public company traded under the ticker IPSC in the American market. The company has a market capitalization of approximately $380.5 million. Century Therapeutics focuses on developing innovative cell therapies for cancer treatment.
Latest news from Century Therapeutics, Inc.
Century Therapeutics Appoints Joseph Truitt to Board of Directors
September 9, 2026
Century Therapeutics Reports Second Quarter 2026 Financial Results and Business Updates
August 12, 2026
IHI Power Services Corp. Rebrands as Kyuden Energy Partners Following Acquisition by Japan's Kyuden Group
July 23, 2026
Century Therapeutics Selected for Oral Presentations of CNTY-813 Preclinical Data at EASD 2026 and Breakthrough T1D® Clinical & Research ...
July 9, 2026
New CNTY-813 Preclinical Data Demonstrate Durable Glucose Control, Immune Evasion Under Alloimmune Pressure, and Scalable Manufacturing a...
June 8, 2026
Research Century Therapeutics, Inc.
Century Therapeutics, Inc. investor report
Review AI stock analysis and investor report context for IPSC:NASDAQ.
Century Therapeutics, Inc. company profile
View the public company page for Century Therapeutics, Inc. on 6ix.
Century Therapeutics, Inc. news
Read company news and market updates connected to Century Therapeutics, Inc..
Century Therapeutics, Inc. investor events
Find investor webinars, events, and replay context for Century Therapeutics, Inc..